Qube Research & Technologies (QRT)
HAE icon

Qube Research & Technologies (QRT)’s Haemonetics HAE Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.43M Sell
45,673
-384,479
-89% -$24.7M ﹤0.01% 1827
2026
Q1 		$24.2M Buy
430,152
+294,366
+217% +$19.2M 0.03% 775
2025
Q4 		$10.9M Sell
135,786
-134,578
-50% -$9.04M 0.01% 1295
2025
Q3 		$13.2M Buy
+270,364
New +$16.7M 0.01% 1143
2025
Q2 		– Sell
-34,009
Closed -$2.16M – 3708
2025
Q1 		$2.16M Sell
34,009
-7,866
-19% -$535K ﹤0.01% 1920
2024
Q4 		$3.27M Buy
+41,875
New +$3.36M ﹤0.01% 1692
2024
Q3 		– Sell
-43,122
Closed -$3.57M – 3636
2024
Q2 		$3.57M Buy
+43,122
New +$3.79M 0.01% 1414
2024
Q1 		– Sell
-42,645
Closed -$3.65M – 4635
2023
Q4 		$3.65M Buy
42,645
+42,589
+76,052% +$3.68M 0.01% 1205
2023
Q3 		$5.02K Sell
56
-13,253
-100% -$1.18M ﹤0.01% 3454
2023
Q2 		$1.13M Sell
13,309
-2,407
-15% -$204K ﹤0.01% 1254
2023
Q1 		$1.3M Sell
15,716
-23,897
-60% -$1.93M 0.01% 1188
2022
Q4 		$3.12M Buy
39,613
+15,278
+63% +$1.23M 0.02% 789
2022
Q3 		$1.8M Buy
24,335
+665
+3% +$47.7K 0.01% 971
2022
Q2 		$1.54M Buy
+23,670
New +$1.4M 0.01% 922
2021
Q2 		– Sell
-25,827
Closed -$2.87M – 2470
2021
Q1 		$2.87M Buy
+25,827
New +$3.2M 0.05% 515
2020
Q3 		– Sell
-35,224
Closed -$3.15M – 1843
2020
Q2 		$3.15M Buy
+35,224
New +$3.56M 0.05% 504
2020
Q1 		– Sell
-1,954
Closed -$225K – 1352
2019
Q4 		$225K Buy
+1,954
New +$236K 0.01% 1345
2019
Q3 		– Sell
-2,135
Closed -$257K – 326
2019
Q2 		$257K Buy
+2,135
New +$210K 0.06% 301
2018
Q4 		– Sell
-1,735
Closed -$199K – 542
2018
Q3 		$199K Buy
1,735
+1,294
+293% +$134K 0.03% 511
2018
Q2 		$40K Buy
+441
New +$37.2K 0.03% 586

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Qube Research & Technologies (QRT)'s HAE Position: Q2 2026 in Review

Qube Research & Technologies (QRT) reduced its Haemonetics (HAE) stake by 89% in Q2 2026, selling an estimated $24.7M and leaving 45,673 shares worth $3.43M. The position accounts for ﹤0.01% of the portfolio, ranked #1827.

Qube Research & Technologies (QRT) first reported a position in HAE in Q2 2018 and has held it in 20 quarters since. The position peaked at $24.2M in Q1 2026. 330 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Qube Research & Technologies (QRT) held 45,673 shares of Haemonetics worth $3.43M as of Q2 2026.
  • Qube Research & Technologies (QRT) sold 384,479 Haemonetics shares in Q2 2026, an estimated $24.7M.
  • Haemonetics made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #1827 holding.
  • Qube Research & Technologies (QRT) first reported a position in Haemonetics in Q2 2018 and has held it in 20 quarters since.
  • Qube Research & Technologies (QRT)'s Haemonetics position peaked at $24.2M in Q1 2026.
  • 330 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.